Abstract
Skin and soft-tissue infections are common and generally are uncomplicated at the time of initial presentation. However, these infections can worsen quickly when there are delays in presentation and treatment. Upon encountering these infections, physicians must respond quickly with an appropriate therapeutic plan and be aware of trends in microbial resistance in order to optimize patient care.
MeSH terms
-
Anti-Infective Agents / pharmacology
-
Anti-Infective Agents / therapeutic use*
-
Community-Acquired Infections* / diagnosis
-
Community-Acquired Infections* / drug therapy
-
Community-Acquired Infections* / epidemiology
-
Community-Acquired Infections* / microbiology
-
Early Diagnosis
-
Humans
-
Methicillin Resistance
-
Primary Health Care / methods*
-
Skin Diseases, Infectious* / diagnosis
-
Skin Diseases, Infectious* / drug therapy
-
Skin Diseases, Infectious* / epidemiology
-
Skin Diseases, Infectious* / microbiology
-
Soft Tissue Infections* / diagnosis
-
Soft Tissue Infections* / drug therapy
-
Soft Tissue Infections* / epidemiology
-
Soft Tissue Infections* / microbiology
-
Staphylococcus aureus / drug effects
-
Staphylococcus aureus / isolation & purification